As shown in Table 4, for a prior probability of 0.1, assuming the OR for HCC recurrence was 1.50, the FPRP value was 0.152 for a risk association with patients whose both LPA2 and ATX were higher than the median. This evidence concerns the gene ENPP2 and hepatocellular carcinoma.